These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 18694496)

  • 1. Ethical challenges with the left ventricular assist device as a destination therapy.
    Rizzieri AG; Verheijde JL; Rady MY; McGregor JL
    Philos Ethics Humanit Med; 2008 Aug; 3():20. PubMed ID: 18694496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular assist devices: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2004; 4(3):1-69. PubMed ID: 23074453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perceptions of Bereaved Caregivers and Clinicians About End-of-Life Care for Patients With Destination Therapy Left Ventricular Assist Devices.
    Chuzi S; Ogunseitan A; Cameron KA; Grady K; Schulze L; Wilcox JE
    J Am Heart Assoc; 2021 Aug; 10(15):e020949. PubMed ID: 34308687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. To explore the prevalence and outcomes of advance care planning for patients with left ventricular assist devices: A review.
    Delmaczynska E; Newham R
    J Clin Nurs; 2019 May; 28(9-10):1365-1379. PubMed ID: 30552798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matters to address prior to introducing new life support technology in Japan: three serious ethical concerns related to the use of left ventricular assist devices as destination therapy and suggested policies to deal with them.
    Asai A; Masaki S; Okita T; Enzo A; Kadooka Y
    BMC Med Ethics; 2018 Feb; 19(1):12. PubMed ID: 29482542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular assist devices as destination therapy: a new look at survival.
    Park SJ; Tector A; Piccioni W; Raines E; Gelijns A; Moskowitz A; Rose E; Holman W; Furukawa S; Frazier OH; Dembitsky W
    J Thorac Cardiovasc Surg; 2005 Jan; 129(1):9-17. PubMed ID: 15632819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palliative care and end-of-life issues in patients treated with left ventricular assist devices as destination therapy.
    Swetz KM; Ottenberg AL; Freeman MR; Mueller PS
    Curr Heart Fail Rep; 2011 Sep; 8(3):212-8. PubMed ID: 21538039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethical challenges with deactivation of durable mechanical circulatory support at the end of life: left ventricular assist devices and total artificial hearts.
    Rady MY; Verheijde JL
    J Intensive Care Med; 2014; 29(1):3-12. PubMed ID: 22398630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-care and communication issues at the end of life of recipients of a left-ventricular assist device as destination therapy.
    Ben Gal T; Jaarsma T
    Curr Opin Support Palliat Care; 2013 Mar; 7(1):29-35. PubMed ID: 23314013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left Ventricular Assist Devices for Destination Therapy: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2016; 16(3):1-60. PubMed ID: 27026798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upstream palliative care for the patient with a left ventricular assist device as destination therapy.
    Byram EK
    Dimens Crit Care Nurs; 2012; 31(1):18-24. PubMed ID: 22156807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Palliative care in patients with left ventricular assist devices: systematic review].
    Tenge T; Schlieper D; Schallenburger M; Meier S; Schwartz J; Neukirchen M
    Anaesthesist; 2021 Dec; 70(12):1044-1050. PubMed ID: 33931802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
    Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular assist device therapy for end-stage congestive heart failure: from REMATCH to the future.
    Smart FW; Palanichamy N
    Congest Heart Fail; 2005; 11(4):188-91; quiz 192-3. PubMed ID: 16106120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac extracorporeal life support: state of the art in 2007.
    Cooper DS; Jacobs JP; Moore L; Stock A; Gaynor JW; Chancy T; Parpard M; Griffin DA; Owens T; Checchia PA; Thiagarajan RR; Spray TL; Ravishankar C
    Cardiol Young; 2007 Sep; 17 Suppl 2():104-15. PubMed ID: 18039404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices?
    Sabashnikov A; Popov AF; Bowles CT; Mohite PN; Weymann A; Hards R; Hedger M; Wittwer T; Wippermann J; Wahlers T; Schoendube FA; Simon AR
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1115-21; discussion 1021-2. PubMed ID: 25129605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Will left-ventricular assist device therapy replace heart transplantation in the foreseeable future?
    Lietz K; Miller LW
    Curr Opin Cardiol; 2005 Mar; 20(2):132-7. PubMed ID: 15711200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are biventricular assist devices underused as a bridge to heart transplantation in patients with a high risk of postimplant right ventricular failure?
    Bartfay SE; Dellgren G; Lidén H; Holmberg M; Gäbel J; Redfors B; Bech-Hanssen O; Karason K
    J Thorac Cardiovasc Surg; 2017 Feb; 153(2):360-367.e1. PubMed ID: 27955912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanical Ventricular Assistance as Destination Therapy for End-Stage Heart Failure: Has it Become a First Line Therapy?
    Bonacchi M; Harmelin G; Bugetti M; Sani G
    Front Surg; 2015; 2():35. PubMed ID: 26284251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and cost-effectiveness of left ventricular assist devices as destination therapy for people with end-stage heart failure: a systematic review and economic evaluation.
    Clegg AJ; Scott DA; Loveman E; Colquitt J; Royle P; Bryant J
    Int J Technol Assess Health Care; 2007; 23(2):261-8. PubMed ID: 17493313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.